Dozens of testosterone lawsuits have been filed in U.S. courts on behalf of men who allegedly suffered serious cardiovascular problems due to many of the medications covered in the Health Canada alert.
New York, New York (PRWEB) July 16, 2014
As testosterone treatment lawsuits (http://www.testosteronelawsuitclaims.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that Health Canada has issued a regulatory alert in that country detailing the possible association between low testosterone therapy and cardiovascular problems, including heart attacks, strokes and blood clots. According to the July 16th alert, a review conducted by the agency found a growing body of evidence linking the use of prescription testosterone treatments to serious and possibly life-threatening heart and blood vessel problems such as heart attack, stroke, blood clot in the lungs or legs; and increased or irregular heart rate. Health Canada is now working with the manufacturers of low testosterone therapies to update their product labels with information regarding this potential risk. Medications covered by the Health Canada alert include: Androderm, Andriol, Delatestryl, Androgel, Axiron, Depo-Testosterone, and Testim,*
“Dozens of testosterone lawsuits have been filed in U.S. courts on behalf of men who allegedly suffered serious cardiovascular problems due to many of the medications covered in the Health Canada alert. Our Firm also continues to receive inquiries on a regular basis from others who claim to have suffered similar injuries,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm offers free legal reviews to men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other heart injuries allegedly due to low testosterone treatments.
Court records indicate that more than 150 testosterone lawsuits that were filed on behalf of men who allegedly suffered serious heart events due to their use of drugs like AndroGel are currently pending in a multidistrict litigation underway in U.S. District Court, Northern District of Illinois. Among other things, the claims similarly allege that the manufacturers of testosterone replacement therapies failed to provide adequate warnings regarding the cardiovascular risks associated with their products. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)
The litigation surrounding low testosterone therapy has been growing since January, when the U.S. Food & Drug Administration (FDA) announced it was reviewing the heart risks associated with this class of medication. The FDA was prompted to act by the publication of two studies which indicated that older men, as well as those with pre-existing heart disease, were more likely to suffer heart attacks, strokes or death if they were undergoing low testosterone therapy.
Men who may have been harmed due to their use of drugs like Androgel may be entitled to file their own testosterone treatment lawsuit. To learn more, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
*healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/40587a-eng.php, Health Canada, July 16, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com